7 results
8-K
VERV
Verve Therapeutics Inc
15 Jun 23
Entry into a Material Definitive Agreement
6:37am
is subject to obtaining any necessary consents and approvals, including review by the appropriate regulatory agencies under the Hart-Scott-Rodino Antitrust
8-K
EX-99.1
VERV
Verve Therapeutics Inc
10 Aug 23
Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results
7:00am
and royalties). The collaboration became effective in July following expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements
- Prev
- 1
- Next